4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-022825
Chief Financial Officer gave up 286 shares (to pay taxes)
- Chief Financial Officer acquired 1,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Balthaser Kevin Chief Financial Officer | 2024-09-01 | Option exercise | +1,000 | 24,983 | D | ||
| Balthaser Kevin Chief Financial Officer | 2024-09-01 | Shares withheld for taxes | −286 | $1.18 | $337 | 24,697 | D |
| Derivatives | |||||||
| Balthaser Kevin Chief Financial Officer | 2024-09-01 | Option exercise · Restricted Stock Units | −1,000 | 0 | D | ||
Loading xslF345X05/form4-09042024_100921.xml…